Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 194
Titolo Data di pubblicazione Autore(i) File
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patients 1992 Matera L; Ciccarelli E; Muccioli G; Cesano A; Grottoli S; Oberholtzer E; Camanni F.
Normal development of lymphokine activated killing (LAK) in peripheral blood lymphocytes from hyperprolactinemic patients. 1992 MATERA L ;CICCARELLI E ;MUCCIOLI G ;CESANO A ;GROTTOLI S ;OBERHOLTZER E ;CAMANNI F
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal aging. 1994 GHIGO E ;ARVAT E ;RIZZI G ;GOFFI S ;GROTTOLI S ;MUCCI M ;BOGHEN MF ;CAMANNI F
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjects. 1994 ARVAT E ;GIANOTTI L ;GROTTOLI S ;IMBIMBO BP ;LENAERTS V ;DEGHENGHI R ;CAMANNI F ;GHIGO E
Prolactin receptors in human pituitary adenomas. 1995 CICCARELLI E; FACCANI G; LONGO A; DALLE ORE G; PAPOTTI M; GROTTOLI S; RAZZORE P; GHE' C; MUCCIOLI G
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. 1995 ARVAT E ;GIANOTTI L ;RAMUNNI J ;GROTTOLI S ;BROSSA PC ;BERTAGNA A ;CAMANNI F ;GHIGO E
Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome. 1995 PROCOPIO M ;INVITTI C ;MACCARIO M ;GROTTOLI S ;CAVAGNINI F ;CAMANNI F ;GHIGO E
Blunted GH response to growth hormone-releasing hormone (GHRH) alone or combined with arginine in non-insulin-dependent diabetes mellitus. 1995 MARTINA V ;BRUNO G ;TAGLIABUE M ;BERTAINA S ;MACCARIO M ;GROTTOLI S ;PROCOPIO M ;OZZELLO A ;CAMANNI F
Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. 1995 MACCARIO M ;ARVAT E ;PROCOPIO M ;GIANOTTI L ;GROTTOLI S ;IMBIMBO BP ;LENAERTS V ;DEGHENGHI R ;CAMANNI F ;GHIGO E
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose. 1995 MACCARIO M ;PROCOPIO M ;GROTTOLI S ;OLEANDRI SE ;RAZZORE P ;CAMANNI F ;GHIGO E
Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. 1995 PROCOPIO M ;MACCARIO M ;GROTTOLI S ;OLEANDRI SE ;BOFFANO GM ;CAMANNI F ;GHIGO E
Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients. 1996 CICCARELLI E.; GROTTOLI S.; RAZZORE P.; GIANOTTI L.; E. ARVAT; DEGHENGHI R.; CAMANNI F; GHIGO E.
In obesity, glucose load loses its early inhibitory, but maintains its late 1996 GROTTOLI S; PROCOPIO M; MACCARIO; ZINI; E. GHIGO
Human aging and the GH-IGF-I axis. 1996 GHIGO E ;ARVAT E ;GIANOTTI L ;RAMUNNI J ;DIVITO L ;MACCAGNO B ;GROTTOLI S ;CAMANNI F
Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. 1996 GHIGO E ;ARVAT E ;GIANOTTI L ;GROTTOLI S ;RIZZI G ;CEDA GP ;BOGHEN MF ;DEGHENGHI R ;CAMANNI F
Galanin positively modulates prolactin secretion in normal women. 1996 GROTTOLI S ;ARVAT E ;GIANOTTI L ;RAMUNNI J ;DI VITO L ;MACCAGNO B ;CICCARELLI E ;CAMANNI F ;GHIGO E
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndrome. 1996 ARVAT E ;GIANOTTI L ;RAGUSA L ;VALETTO MR ;CAPPA M ;AIMARETTI G ;RAMUNNI J ;GROTTOLI S ;CAMANNI F ;GHIGO E
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity. 1996 GROTTOLI S ;MACCARIO M ;PROCOPIO M ;OLEANDRI SE ;ARVAT E ;GIANOTTI L ;DEGHENGHI R ;CAMANNI F ;GHIGO E
Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. 1996 MACCARIO M ;GROTTOLI S ;RAZZORE P ;PROCOPIO M ;OLEANDRI SE ;CICCARELLI E ;CAMANNI F ;GHIGO E
Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity. 1996 MACCARIO M ;PROCOPIO M ;GROTTOLI S ;OLEANDRI SE ;BOFFANO GM ;TALIANO M ;CAMANNI F ;GHIGO E
Mostrati risultati da 1 a 20 di 194
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile